Items where authors include "Isaacs, JD"

Export as [feed] Atom [feed] RSS
Number of items: 34.

Article

Curry, PDK, Chinoy, H, Jani, M et al. (8 more authors) (2023) The impact of COVID-19 on medication adherence in a rheumatoid (BRAGGSS) and psoriatic arthritis (OUTPASS) UK cohort. The Journal of Rheumatology, 50 (7). jrheum.2022-1277. ISSN 0315-162X

Hum, RM, Ho, P, Nair, N et al. (8 more authors) (2023) Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. Rheumatology, 62 (6). pp. 2090-2097. ISSN 1462-0324

Smith, SL, Alexander, S, Nair, N et al. (8 more authors) (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Robinson, JI orcid.org/0000-0001-5425-7520, Md Yusof, MY orcid.org/0000-0003-3131-9121, Davies, V et al. (20 more authors) (2022) Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. eBioMedicine, 86. 104343. ISSN 2352-3964

Sutcliffe, M, Nair, N, Oliver, J et al. (9 more authors) (2022) Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy. Rheumatology, 61 (12). pp. 4935-4944. ISSN 1462-0324

Cooles, FAH, Tarn, J, Lendrem, DW et al. (19 more authors) (2022) Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming. Annals of the Rheumatic Diseases, 81 (9). pp. 1214-1223. ISSN 0003-4967

Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Alunno, A, Najm, A, Machado, PM et al. (21 more authors) (2021) 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases. ISSN 0003-4967

Pratt, AG, Siebert, S, Cole, M et al. (13 more authors) (2021) Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. The Lancet Rheumatology, 3 (5). e337-e346. ISSN 2665-9913

Alunno, A, Najm, A, Machado, PM et al. (21 more authors) (2021) EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases. ISSN 0003-4967

Nash, P, Kerschbaumer, A, Dörner, T et al. (26 more authors) (2021) Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the Rheumatic Diseases, 80 (1). pp. 71-87. ISSN 0003-4967

Gilani, SSA, Nair, N, Plant, D et al. (8 more authors) (2020) Pharmacogenetics of TNFi Response in Rheumatoid Arthritis Utilising the Two-Component Disease Activity Score. The Pharmacogenomics Journal, 21 (16). ISSN 1470-269X

Siebert, S, Pratt, AG, Stocken, DD orcid.org/0000-0001-8031-1738 et al. (9 more authors) (2020) Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial. Medicine, 99 (26). e20458. ISSN 0025-7974

Nair, N, Plant, D, Verstappen, SM et al. (6 more authors) (2020) Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis. Rheumatology, 59 (6). pp. 1364-1371. ISSN 1462-0324

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Al-Laith, M, Jasenecova, M, Abraham, S et al. (27 more authors) (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials, 20 (1). 429. p. 429. ISSN 1745-6215

Ridgley, LA, Anderson, AE, Maney, NJ et al. (7 more authors) (2019) IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function. Frontiers in Immunology, 10. 1535. ISSN 1664-3224

Kearsley-Fleet, L, Davies, R, De Cock, D et al. (6 more authors) (2018) Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 77 (10). pp. 1405-1412. ISSN 0003-4967

Taylor, JC orcid.org/0000-0002-2518-5799, Bongartz, T, Massey, J et al. (37 more authors) (2018) Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients. The Pharmacogenomics Journal, 18 (4). pp. 528-538. ISSN 1470-269X

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. Nature Reviews Rheumatology, 14 (2). p. 119. ISSN 1759-4790

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) The RA-MAP Consortium: A working model for academia-industry collaboration. Nature Reviews Rheumatology, 14 (1). pp. 53-60. ISSN 1759-4790

Orr, C, Vieira-Sousa, E, Boyle, DL et al. (26 more authors) (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology, 13 (8). pp. 463-475. ISSN 1759-4790

Smith, SL, Plant, D, Eyre, S et al. (5 more authors) (2017) The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort. Rheumatology, 56 (6). pp. 1019-1024. ISSN 1462-0324

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2016) Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. Rheumatology, 55 (11). pp. 2050-2055. ISSN 1462-0324

Plant, D, Webster, A, Nair, N et al. (9 more authors) (2016) Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis. Arthritis and Rheumatology, 68 (6). pp. 1353-1360. ISSN 2326-5191

Bluett, J, Morgan, C, Thurston, L et al. (7 more authors) (2015) Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology, 54 (3). pp. 494-499. ISSN 1462-0324

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

Bluett, J, Ibrahim, I, Plant, D et al. (6 more authors) (2014) Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Pharmacogenomics Journal, 14 (2). pp. 171-175. ISSN 1470-269X

Plant, D, Ibrahim, I, Lunt, M et al. (8 more authors) (2012) Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Research and Therapy, 14 (5). R214. ISSN 1478-6354

Robinson, JI, Carr, IM, Cooper, DL et al. (9 more authors) (2012) Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Human Mutation, 33 (4). 741 - 749 . ISSN 1059-7794

Craddock, N, Hurles, ME, Cardin, N et al. (215 more authors) (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 464 (7289). pp. 713-720. ISSN 0028-0836

Conference or Workshop Item

Brown, P, Anderson, A, Hargreaves, B et al. (3 more authors) (2021) OP0033 REGULATORY T CELL CD39 EXPRESSION AS A PREDICTOR OF EARLY REMISSION-INDUCTION WITH METHOTREXATE IN NEW-ONSET RHEUMATOID ARTHRITIS. In: EULAR 2021, 02-05 Jun 2021, Online.

David, T, Nair, N, Oliver, J et al. (8 more authors) (2021) POS0357 MiRNAs CORRELATE WITH IMPROVEMENT IN DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TUMOUR NECROSIS FACTOR INHIBITORS. In: EULAR 2021, 02-05 Jun 2021, Online.

This list was generated on Sat Mar 23 23:10:53 2024 GMT.